Search Results - torben+falck+%c3%b8rntoft

1 Results

Sort By:

Methylation biomarkers for prostate cancer

Novel diagnostic and prognostic markers for prostate cancer using methylated DNA. Technical Field Biotech, Pharma Business opportunity Research collaboration to validate the technology Current state of technology Methylation-sensitive qPCR (MS-qPCR) assays have been developed and tested in ~500 clinical samples from prostate...

Published: 9/12/2025 | Updated: 12/5/2012 | Inventor(s): Karina Dalsgaard Sørensen, Christa Haldrup, Torben Falck Ørntoft

Keywords(s): Diagnostics, White Biotech, z_DoNotUse_PrognosisScreening

Category(s): Life Sciences and Medical Devices